[HTML][HTML] Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers

I Bojanic, N Worel, CP Pacini, G Stary… - Frontiers in …, 2023 - frontiersin.org
Haematopoietic stem cell transplantation (HSCT) is the treatment of choice for malignant
haematological diseases. Despite continuous improvements in pre-and post-transplantation …

[HTML][HTML] Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers

I Bojanic, N Worel, CP Pacini, G Stary… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
Haematopoietic stem cell transplantation (HSCT) is the treatment of choice for malignant
haematological diseases. Despite continuous improvements in pre-and post-transplantation …

[HTML][HTML] Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers

I Bojanic, N Worel, CP Pacini, G Stary… - Frontiers in …, 2023 - frontiersin.org
Haematopoietic stem cell transplantation (HSCT) is the treatment of choice for malignant
haematological diseases. Despite continuous improvements in pre-and post-transplantation …

Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers

I Bojanić, N Worel, CP Pacini, G Stary… - Frontiers in …, 2023 - repozitorij.unizg.hr
Allogeneic haematopoietic stem cell transplantation (HSCT) is a potentially curative
treatment for a variety of haematologic and non-haematologic disorders. Despite …

Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers

I Bojanić, N Worel, CP Pacini, G Stary… - Frontiers in …, 2023 - repozitorij.mef.unizg.hr
Abstract (english) Haematopoietic stem cell transplantation (HSCT) is the treatment of
choice for malignant haematological diseases. Despite continuous improvements in pre-and …

Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers.

I Bojanic, N Worel, CP Pacini, G Stary… - Frontiers in …, 2023 - europepmc.org
Haematopoietic stem cell transplantation (HSCT) is the treatment of choice for malignant
haematological diseases. Despite continuous improvements in pre-and post-transplantation …

Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers

I Bojanic, N Worel, CP Pacini, G Stary… - Frontiers in …, 2023 - pubmed.ncbi.nlm.nih.gov
Haematopoietic stem cell transplantation (HSCT) is the treatment of choice for malignant
haematological diseases. Despite continuous improvements in pre-and post-transplantation …

Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers

I Bojanic, N Worel, CP Pacini, G Stary… - Frontiers in …, 2023 - eprints.ncl.ac.uk
Allogeneic haematopoietic stem cell transplantation (HSCT) is a potentially curative
treatment for a variety of haematologic and non-haematologic disorders. Despite …

[PDF][PDF] Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers

I Bojanic, N Worel, CP Pacini, G Stary, A Piekarska… - 2023 - repozitorij.mef.unizg.hr
Allogeneic haematopoietic stem cell transplantation (HSCT) is a potentially curative
treatment for a variety of haematologic and non-haematologic disorders. Despite …

[PDF][PDF] Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers

I Bojanic, N Worel, CP Pacini, G Stary, A Piekarska… - 2023 - repozitorij.unizg.hr
Allogeneic haematopoietic stem cell transplantation (HSCT) is a potentially curative
treatment for a variety of haematologic and non-haematologic disorders. Despite …